Thursday, May 7, 2009
VGX and Swine Flu Vaccines
John Gorge writes in his Philadelphia Business Journal healthcare blog about Joseph Kim. No, not me, but another Joseph Kim. Dr. J. Joseph Kim is the CEO of VGX Pharmaceuticals, a biotechnology company that uses some novel approaches to vaccine development. Dr. Kim also happens to be an MIT alumni, so we do share a few things in common. Like me, he has a strong passion for medical technology. That's what his company is about. He uses electroporation technology to develop DNA-based vaccines and it sounds like they're eager to work on a swine flu vaccine.
It sounds like VGX is merging with Inovio Biomedical Corp. of San Diego and they will operate as VGX.